RecalledThisWeek Search
High risk Drugs & MedicationsClass II

Payless Compounders Semaglutide Injectable Recall

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Updated March 6, 2026

Semaglutide-Glycine-Cyanocobalamin Injectable vials from Payless Compounders have not been verified as sterile and may be contaminated. Using a non-sterile injection increases the risk of serious infection.

Is the PAYLESS COMPOUNDERS, LLC recalled? Yes. This product was recalled by FDA on March 6, 2026. Details below.

What is recalled

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, and 1 mg/mL, in 0.5 mL vials (prescription-only), manufactured by Northwest Compounders, Beaverton, OR, and distributed by Payless Compounders, LLC.

Am I affected

You're affected if you have vials of Semaglutide-Glycine-Cyanocobalamin Injectable labeled as 2.5 mg, 5 mg, or 1 mg/mL in 0.5 mL single-dose vials from Payless Compounders or Northwest Compounders.

What to do right now

Stop using this product immediately. Contact your healthcare provider or pharmacy for guidance on obtaining a replacement prescription from a verified sterile source. Do not use any remaining vials.

The hazard

Lack of Assurance of Sterility

Brands affected

PAYLESS COMPOUNDERS, LLC
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0471-2026
Classification
Class II
Recalled
March 6, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls